Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

CMS announces billions in savings for Medicare when first and second rounds of negotiations go into effect in 2026 and 2027, ...

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

The cuts stem from the Inflation Reduction Act, not Trump’s “most favored nation” approach, and apply to what Medicare pays ...

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.

Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes that will affect your wallet.

The new rule is expected to extend the telemedicine flexibilities through the end of 2026 and will maintain the status quo while the DEA and the Department of Health and Human Services work toward a ...

Merck and Elevance Health stocks are top dividend growth picks with solid yields and attractive valuations. Click here to learn more about MRK and ELV.

By Patrick Wingrove Dec 4 (Reuters) - Billionaire Mark Cuban has urged the Trump administration to waive the hundreds of ...

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

WASHINGTON — The Trump administration on Tuesday evening unveiled the prices for 15 drugs that were the subject of Medicare ...